OSMOS Clinical Research, Inc. is the premier consultancy firm advising pharmaceutical, biotechnology and medical device companies in conducting clinical trials in emerging markets around the world.
Headquartered in South San Francisco, California, the hub of biotech and pharmaceutical activity, we have been helping to advance medical breakthroughs since early 2004. OSMOS was started by Boris Iossel, a medical professional with many years of experience in clinical research and a native Russian speaker, to address a growing demand for specific expertise in clinical research trials in Eastern Europe and Russia. Since then, we have become the leading expert group on trials in that region.
Over the last few years, OSMOS has expanded our services to cover new regions opening up for clinical research, such as India and Latin America. In addition to our own multicultural and multilingual staff, we employ trained and trusted associates in these emerging markets. We have selected local physicians with proven track records in monitoring, managing and ensuring safety, quality and compliance in clinical trials who share our passion for excellence at every stage in the clinical research process.
At OSMOS, we understand that change happens at lightening speed and can affect our clients’ work almost immediately. That’s why we are committed to staying one step ahead of the curve by constantly monitoring and analyzing important developments and news related to clinical research activities in the emerging regions. This also means we are continuously updating our network of local and international vendors and consultants. Our goal is to offer you the best service in the most appropriate location for your project.
Over the years, OSMOS has contributed significantly to our clients’ success. Read their testimonials and learn why they turn to us again and again for their most important projects. Then, contact us to find out how we can help you too.
“We were very pleased with the services performed in Russia by OSMOS. They were professional in every aspect of their work, including client interactions, contractual discussions and conduct of the audits. We will definitely use them again when the need arises for audit and trial-related services in Eastern Europe.”
T.B., Clinical Manager
Top Ten Multinational Pharmaceutical Company
“It was worth every penny!”
P.M., CFO
Bay Area Pharmaceutical Company
“It would be much more difficult to run our study without the help from OSMOS. Their expertise and diligent work allowed us to avoid or resolve many complex issues that you will encounter in your trials in foreign countries...”
D.T., VP Clinical Development
Bay Area Biotechnology Company
“Boris and his colleagues at OSMOS contributed greatly to the success of a clinical trial in Russia. They participated in CRO selection, ensured effective communication between the sponsor (my company) and the Russian CRO during the conduct of the trial, and provided co-monitoring support to ensure the data in our database was reflected in patient charts. I would definitely return to OSMOS for future trials in their regions of expertise.”
T.B., Chief Medical Officer
Biotechnology Company
© 2010, OSMOS Clinical Research, Inc.